384 related articles for article (PubMed ID: 21084776)
1. Management of complicated urinary tract infections in the era of antimicrobial resistance.
Bader MS; Hawboldt J; Brooks A
Postgrad Med; 2010 Nov; 122(6):7-15. PubMed ID: 21084776
[TBL] [Abstract][Full Text] [Related]
2. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region.
Hsueh PR; Hoban DJ; Carmeli Y; Chen SY; Desikan S; Alejandria M; Ko WC; Binh TQ
J Infect; 2011 Aug; 63(2):114-23. PubMed ID: 21669223
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs.
Moffett SE; Frazee BW; Stein JC; Navab B; Maselli J; Takhar SS; Gonzales R
Am J Emerg Med; 2012 Jul; 30(6):942-9. PubMed ID: 21802879
[TBL] [Abstract][Full Text] [Related]
4. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance in children with recurrent or complicated urinary tract infection.
Younis N; Quol K; Al-Momani T; Al-Awaisheh F; Al-Kayed D
JNMA J Nepal Med Assoc; 2009; 48(173):14-9. PubMed ID: 19529052
[TBL] [Abstract][Full Text] [Related]
7. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
Matthews SJ; Lancaster JW
Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
[TBL] [Abstract][Full Text] [Related]
8. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
Johnson L; Sabel A; Burman WJ; Everhart RM; Rome M; MacKenzie TD; Rozwadowski J; Mehler PS; Price CS
Am J Med; 2008 Oct; 121(10):876-84. PubMed ID: 18823859
[TBL] [Abstract][Full Text] [Related]
9. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
Gagliotti C; Buttazzi R; Sforza S; Moro ML;
J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
[TBL] [Abstract][Full Text] [Related]
10. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
[TBL] [Abstract][Full Text] [Related]
11. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G
Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
13. Urinary tract infection in women over the age of 65: is age alone a marker of complication?
Grover ML; Bracamonte JD; Kanodia AK; Edwards FD; Weaver AL
J Am Board Fam Med; 2009; 22(3):266-71. PubMed ID: 19429732
[TBL] [Abstract][Full Text] [Related]
14. [Impact of regional guidelines on the management of urinary tract infections with antibiotics].
Ruyer O; Slekovec C; Bertrand X; Faller JP; Hoen B; Talon D; Leroy J
Med Mal Infect; 2010 Jun; 40(6):352-7. PubMed ID: 20172675
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals.
Eagye KJ; Kuti JL; Sutherland CA; Christensen H; Nicolau DP
Clin Ther; 2009 Nov; 31(11):2678-88. PubMed ID: 20110010
[TBL] [Abstract][Full Text] [Related]
16. Ofloxacin: new applications for the prevention of urinary tract infections in renal graft recipients.
Rafat C; Vimont S; Ancel PY; Xu-Dubois YC; Mesnard L; Ouali N; Denis M; Vandewalle A; Rondeau E; Hertig A
Transpl Infect Dis; 2011 Aug; 13(4):344-52. PubMed ID: 21299776
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
[TBL] [Abstract][Full Text] [Related]
18. Urinary tract infections in hospital pediatrics: many previous antibiotherapy and antibiotics resistance, including fluoroquinolones.
Garraffo A; Marguet C; Checoury A; Boyer S; Gardrat A; Houivet E; Caron F
Med Mal Infect; 2014 Feb; 44(2):63-8. PubMed ID: 24512734
[TBL] [Abstract][Full Text] [Related]
19. [Uncomplicated urinary tract infection and treatment].
Wagenlehner FM; Vahlensieck W; Watermann D; Weidner W; Naber KG
Aktuelle Urol; 2011 Jan; 42(1):33-7. PubMed ID: 21267803
[TBL] [Abstract][Full Text] [Related]
20. Urinary tract infections.
Wang A; Nizran P; Malone MA; Riley T
Prim Care; 2013 Sep; 40(3):687-706. PubMed ID: 23958364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
